 This is a multicentre, multinational, open-label, single treatment arm study of intravenous IV ceftaroline fosamil and ampicillin, plus an optional aminoglycoside of choice, in hospitalized neonates and young infants aged 7 to 60 days with late-onset sepsis LOS. 